Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_assertion type Assertion NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_head.
- NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_assertion description "[Here we report the identification of a secondary mutation in ALK, F1174L, as one cause of crizotinib resistance in a patient with an inflammatory myofibroblastic tumor (IMT) harboring a RANBP2-ALK translocation who progressed while on crizotinib therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_provenance.
- NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_assertion evidence source_evidence_literature NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_provenance.
- NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_assertion SIO_000772 21030459 NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_provenance.
- NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_assertion wasDerivedFrom befree-2016 NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_provenance.
- NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_assertion wasGeneratedBy ECO_0000203 NP848913.RATQ2qihdMJyY0XBZ6AKXv_rac6VeDO7W8VwvvE1N9ujM130_provenance.